Pharmaceutical Residues in Senior Residences Wastewaters: High Loads, Emerging Risks
Other authors
Publication date
2021-08-20ISSN
1420-3049
Abstract
Senior residences are health-care facilities that are socially-accepted for the assistance of elderly people. Since the elderly account for the foremost pharmaceutical-consuming age-group, senior residences become a hot-spot for pharmaceuticals discharge to the sewage grid. The objectives of the present study were to identify the bioactive pharmaceuticals in sewage waters from senior residences and to propose an on-site monitoring strategy for their control. In this study, we have studied the presence of 43 pharmaceuticals highly consumed by the elderly population in six senior residences located in Spain, France and Portugal. Wastewater was sampled directly from the water-chest in each residence during different times of the day throughout one week. Main compounds detected at the high µg L−1 level were analgesic and antipyretic drugs such as acetylsalicylic acid, paracetamol, ibuprofen; antibiotics such as amoxicillin and sulfamethoxazole; compounds for the treatment of neuropathies as gabapentin, trazodone and valsartan; pharmaceuticals for the treatment of diabetes (vildagliptin) and anticancer drugs. The daily loads discharged were estimated and their fate was evaluated. The final objective of this study is to highlight the need to implement at-source waste water treatment procedures in senior residences, which have been identified as a point source pollution of pharmaceuticals.
Document Type
Article
Document version
Published version
Language
English
Subject (CDU)
615 - Pharmacology. Therapeutics. Toxicology
Keywords
senior residences
wastewater
pharmaceuticals
sewage grid
Pages
18 p.
Publisher
MDPI
Is part of
Molecules 2021;26(16):5047
Grant agreement number
info: eu-repo/grantAgreement/MCIU/PN I+D/PID2019-105732GB-C21
info:eu-repo/grantAgreement/FEDER/Interreg SUDOE/Project SOE1/P1/F0173
This item appears in the following Collection(s)
Rights
© L'autor/a
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/